BOLT vs O · rev $7.7M vs P/E 50, rev $5.27B
Bolt Biotherapeutics (BOLT) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
BOLT currently screens at market cap $11.3M. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the BOLT and O stock pages for the full models.
Not investment advice.